Journal of Molecular Neuroscience logo Humana Press logo

Publisher: Humana Press

Volume 20, Number 3, August 2003
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Genetic and environmental epidemiology of Alzheimer's disease in arabs residing in Israel
pp. 207-212(6)
Authors: Farrer, Lindsay; Friedland, Robert; Bowirrat, Abdalla; Waraska, Kristin; Korczyn, Amos; Baldwin, Clinton

Enhancing brain and cognitive function of older adults through fitness training
pp. 213-221(9)
Authors: Kramer, Arthur; Colcombe, Stanley; McAuley, Edward; Eriksen, Kirk; Scalf, Paige; Jerome, Gerald; Marquez, David; Elavsky, Steriani; Webb, Andrew

Relationship between the induction of RAGE cell-surface antigen and the expression of amyloid binding sites
pp. 223-232(10)
Authors: Mruthinti, Shyamala; Hill, William; Swamy-Mruthinti, Satyanarayana; Buccafusco, Jerry

β-secretase processing of the Alzheimer's amyloid protein precursor (APP)
pp. 233-239(7)
Authors: Marlow, Laura; Cain, Melissa; Pappolla, Miguel; Sambamurti, Kumar

Hippocampal volume is associated with memory but not nonmemory cognitive performance in patients with mild cognitive impairment
pp. 241-248(8)
Authors: Grundman, Michael; Jack, Clifford; Petersen, Ronald; Kim, Hyun; Taylor, Curtis; Datvian, Marina; Weiner, Myron; DeCarli, Charles; DeKosky, Steven; Dyck, Christopher; Darvesh, Sultan; Yaffe, Kristine; Kaye, Jeffrey; Ferris, Steven; Thomas, Ronald; Thal, Leon

Characterization of radioiodinated ligand binding to amyloid β plaques
pp. 249-253(5)
Authors: Kung, Mei-Ping; Zhuang, Zhi-Ping; Hou, Catherine; Jin, Lee-Way; Kung, Hank

Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives
pp. 255-260(6)
Authors: Wang, Yanming; Mathis, Chester; Huang, Guo-Feng; Debnath, Manik; Holt, Daniel; Shao, Li; Klunk, William

Peptide nucleic acids targeted to the amyloid precursor protein
pp. 261-265(5)
Authors: McMahon, Beth; Stewart, Jennifer; Fauq, Abdul; Younkin, Steven; Younkin, Linda; Richelson, Elliott

Drug discovery targeted to the Alzheimer's APP mRNA 5′-untranslated region: The action of paroxetine and dimercaptopropanol
pp. 267-275(9)
Authors: Payton, Sandra; Cahill, Catherine; Randall, Jeffrey; Gullans, Steven; Rogers, Jack

Potential use of estrogen-like drugs for the prevention of Alzheimer's disease
pp. 277-281(5)
Authors: Smith, Jonathan; Levin-Allerhand, Justine

Immunological approach for the treatment of Alzheimer's disease
pp. 283-286(4)
Author: Solomon, Beka

The possible role of tissue-type plasminogen activator (tPA) and tPA blockers in the pathogenesis and treatment of Alzheimer's disease
pp. 287-289(3)
Authors: Melchor, Jerry; Pawlak, Robert; Chen, Zulin; Strickland, Sidney

Novel glycosaminoglycan precursors as anti-amyloid agents, Part III
pp. 291-297(7)
Authors: Kisilevsky, Robert; Szarek, Walter; Ancsin, John; Bhat, Shridhar; Li, Zhanjiang; Marone, Sandra

Study of memapsin 2 (β-secretase) and strategy of inhibitor design
pp. 299-304(6)
Authors: Tang, Jordan; Ghosh, Arun; Hong, Lin; Koelsch, Gerald; Turner, Robert; Chang, Wanpin

Femtomole immunodetection of synthetic and endogenous amyloid-β oligomers and its application to Alzheimer's disease drug candidate screening
pp. 305-313(9)
Authors: Chang, Lei; Bakhos, Lara; Wang, Zhiqiang; Venton, Duane; Klein, William

From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP: A view of neuroprotection and cell division
pp. 315-322(8)
Authors: Gozes, Illana; Divinsky, Inna; Pilzer, Inbar; Fridkin, Mati; Brenneman, Douglas; Spier, Avron

Alzheimer's therapeutics: Neurotrophin domain small molecule mimetics
pp. 323-326(4)
Authors: Massa, Stephen; Xie, Youmei; Longo, Frank

Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease
pp. 327-337(11)
Authors: Marques, Marcos; Crutcher, Keith

Overcoming the blood-brain barrier to taxane delivery for neurodegenerative diseases and brain tumors
pp. 339-343(5)
Authors: Rice, Antonie; Michaelis, Mary; Georg, Gunda; Liu, Yanbin; Turunen, Brandon; Audus, Kenneth

Structure-based rational design of chemical ligands for AMPA-subtype glutamate receptors
pp. 345-348(4)
Authors: Zeng, Lei; Chen, Can; Muller, Michaela; Zhou, Ming-Ming

M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: Implications in future therapy
pp. 349-356(8)
Authors: Fisher, Abraham; Pittel, Zipora; Haring, Rachel; Bar-Ner, Nira; Kliger-Spatz, Michal; Natan, Niva; Egozi, Inbal; Sonego, Hagar; Marcovitch, Itzhak; Brandeis, Rachel

Calpain inhibitors, a treatment for alzheimer's disease: Position paper
pp. 357-362(6)
Authors: Battaglia, Fortunato; Trinchese, Fabrizio; Liu, Shumin; Walter, Sean; Nixon, Ralph; Arancio, Ottavio

Progress toward a high-affinity allosteric enhancer at muscarinic M1 receptors
pp. 363-367(5)
Authors: Lazareno, Sebastian; Popham, Angela; Birdsall, Nigel

Acetylcholinesterase: A multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer's disease
pp. 369-383(15)
Authors: Greenblatt, Harry; Dvir, Hay; Silman, Israel; Sussman, Joel

Steroid hormones and cognitive functioning in aging men: A mini-review
pp. 385-393(9)
Author: Sherwin, Barbara

Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol
pp. 395-406(12)
Authors: Petanceska, Suzana; DeRosa, Steven; Sharma, Ali; Diaz, Nichole; Duff, Karen; Tint, Steven; Refolo, Lorenzo; Pappolla, Miguel

A position paper: Based on observational data indicating an increased rate of altered blood chemistry requiring withdrawal from the Alzheimer's disease cholesterol-lowering treatment trial (ADCLT)
pp. 407-410(4)
Authors: Sparks, D.; Lopez, Jean; Connor, Don; Sabbagh, Marwan; Seward, Jim; Browne, Patrick

Discovery of a new class of synthetic protein kinase inhibitors that suppress selective aspects of glial activation and protect against β-amyloid induced injury: A foundation for future medicinal chemistry efforts focused on targeting Alzheimer's disease progression
pp. 411-423(13)
Authors: Watterson, D.; Velentza, Anastasia; Zasadzki, Magdalena; Craft, Jeffrey; Haiech, Jacques; Eldik, Linda

Alzheimer neurofibrillary degeneration: Therapeutic targets and high-throughput assays
pp. 425-429(5)
Authors: Iqbal, Khalid; Alonso, Alejandra; El-Akkad, Ezzat; Gong, Cheng-Xin; Haque, Niloufar; Khatoon, Sabiha; Pei, Jin-Jing; Tanimukai, Hitoshi; Tsujio, Ichiro; Wang, Jian-Zhi; Inge, Grundke-Iqbal

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A